Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is bile duct cancer (cholangiocarcinoma)?
Bile duct cancer, also called cholangiocarcinoma, is a cancer that begins in the bile ducts — the thin tubes that carry bile, a digestive fluid, from the liver and gallbladder to the small intestine. It is an uncommon cancer that is grouped by where along this tubing system it forms, because the location strongly shapes symptoms and treatment. Cancers inside the liver are called intrahepatic; those at the point where the ducts leave the liver are called perihilar (or Klatskin tumors); and those in the duct closer to the intestine are called distal. A very common early sign is painless yellowing of the skin and eyes (jaundice), because a tumor blocks the flow of bile; other signs include itching, dark urine, pale stools, weight loss, and abdominal discomfort. Risk factors include chronic inflammation of the bile ducts, certain liver diseases, and bile duct stones. When the cancer can be removed with surgery, that offers the best chance of cure; when it cannot — which is common because these tumors are often found late or sit in difficult locations — treatment relies on chemotherapy, radiation, procedures to relieve bile blockage, and increasingly, targeted drugs matched to the tumor's genetics. Care is best delivered by an experienced multidisciplinary team.
The main types
Doctors group bile duct cancer (cholangiocarcinoma) by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Intrahepatic cholangiocarcinoma | Bile duct cancer that forms in the small ducts inside the liver; it often appears as a mass in the liver and may be treated with surgery, or with radiation and other liver-directed therapies when it cannot be removed. |
| Perihilar (hilar) cholangiocarcinoma | Cancer at the junction where the main ducts leave the liver — also called a Klatskin tumor; it commonly causes jaundice and sits in a complex location that makes surgery challenging. |
| Distal cholangiocarcinoma | Cancer in the lower part of the bile duct closer to the intestine; when removable, it is often treated with an operation similar to that used for cancers of the pancreas head. |
Staging, in plain terms
Bile duct cancer is staged with the TNM system, but there are different TNM schemes for intrahepatic, perihilar, and distal tumors because they behave and are treated differently. T describes how far the tumor has grown into and around the bile duct or liver, N describes spread to nearby lymph nodes, and M describes spread to distant organs. These combine into stages that, broadly, separate cancers that may be removable by surgery from those that are not. Beyond the stage, the single most important practical question is whether the tumor can be completely removed — this depends on its location, how much it involves nearby blood vessels and the liver, and the patient's overall health. When surgery is possible, it offers the best chance of cure, often followed by chemotherapy. When it is not, the focus shifts to controlling the cancer and relieving symptoms with chemotherapy, radiation, bile-drainage procedures, and targeted therapies.
| TNM (tumor, nodes, metastasis), with separate systems for each location | What it generally means |
|---|---|
| Localized, resectable | The cancer is confined and can potentially be removed with surgery — the best chance of cure, usually followed by chemotherapy. |
| Locally advanced, unresectable | The cancer has grown into nearby blood vessels or structures and cannot be safely removed, but has not spread to distant organs; treated with chemotherapy and radiation to control it and relieve symptoms. |
| Metastatic | The cancer has spread to distant organs such as other parts of the liver, the lining of the abdomen, or the lungs; treatment focuses on chemotherapy, targeted drugs matched to tumor genetics, and symptom relief. |
The standard of care
Bile Duct Cancer (Cholangiocarcinoma) is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery
When the cancer can be completely removed, surgery offers the best chance of cure; the type of operation depends on whether the tumor is inside the liver, at the liver's junction, or lower in the duct.
Chemotherapy
Chemotherapy is used after surgery to lower the chance of recurrence and is a main treatment for advanced disease to slow the cancer and ease symptoms.
Radiation therapy
Radiation helps control tumors that cannot be removed, can be combined with chemotherapy, and includes focused high-dose techniques for selected liver tumors; it also relieves symptoms such as pain or bile blockage.
Targeted therapy
Some bile duct cancers carry specific gene changes (such as FGFR2 fusions or IDH1 mutations) that can be treated with targeted drugs, so testing the tumor's genetics is increasingly important.
Relieving bile blockage
Procedures to place a small tube (stent) or drain can open a blocked bile duct, relieving jaundice and itching and improving the ability to tolerate other treatments.
How radiation treatment works
Radiation uses focused high-energy beams to damage the DNA inside cancer cells so they can no longer grow and divide. In bile duct cancer, radiation is especially valuable when a tumor cannot be removed with surgery — which is common, because these cancers often sit in difficult locations or are found late. Radiation can control a tumor that has grown into nearby blood vessels or structures, relieve symptoms such as pain or blockage of the bile duct, and, for selected tumors inside the liver, deliver a high focused dose to destroy the cancer. Modern techniques make this precise and safe: stereotactic body radiation therapy (SBRT) delivers a powerful dose in just a few sessions while sparing the surrounding liver; IMRT shapes the dose around the tumor while protecting the liver, intestine, and kidneys; and specialized internal radiation can concentrate the dose within the liver. Radiation is often combined with chemotherapy to improve control of locally advanced disease, and it can be used after surgery in selected cases. Because the liver and nearby organs are sensitive, the radiation oncologist carefully plans the dose and uses techniques that account for breathing motion. Your team will tailor radiation to your tumor's location and goals — whether controlling an unremovable cancer or relieving symptoms — while protecting healthy liver and digestive organs.
The main ways radiation is delivered for bile duct cancer (cholangiocarcinoma):
Stereotactic body radiation therapy (SBRT)
SBRT delivers a high, precisely focused radiation dose to a bile duct or liver tumor in a few sessions, controlling cancers that cannot be removed while sparing surrounding liver tissue.
Chemoradiation
Combining radiation with chemotherapy can improve control of locally advanced tumors that have grown into nearby structures and cannot be removed surgically.
External-beam radiation (IMRT)
Intensity-modulated radiation shapes the dose around the tumor while sparing the liver, intestine, and kidneys, and can relieve symptoms such as pain or duct blockage.
Internal and liver-directed radiation
For selected intrahepatic tumors, radiation delivered from inside the duct (brachytherapy) or tiny radioactive beads placed in the tumor's blood supply can concentrate dose within the liver.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Targeted therapy for specific gene changes: Discovery of FGFR2 fusions and IDH1 mutations in some bile duct cancers led to targeted drugs that benefit these patients, making genetic testing of the tumor an important step in advanced disease.[1]
Cholangiocarcinoma targeted therapy trials
Stereotactic radiation for liver tumors: Studies show that high-dose, precisely focused SBRT can achieve strong local control of intrahepatic bile duct tumors that cannot be removed, while sparing healthy liver.[2]
Liver SBRT research
Chemotherapy after surgery: Trials established that giving chemotherapy after surgical removal reduces the chance of the cancer returning and improves survival, making it a standard part of curative-intent treatment.[3]
Adjuvant chemotherapy biliary cancer trials
Common questions
Why does the location of the tumor matter so much? Bile duct cancers are grouped by where they form — inside the liver, at the liver's junction, or lower in the duct — because the location determines the symptoms, the type of surgery possible, and how radiation and other treatments are used. This is why staging and treatment plans differ by location.
What can be done if the cancer can't be removed with surgery? Many bile duct cancers can't be removed, but a lot can still be done: chemotherapy and radiation (including focused high-dose SBRT for some liver tumors) can control the cancer and relieve symptoms, procedures can open a blocked bile duct, and targeted drugs may help if the tumor has certain gene changes. Clinical trials are also worth discussing.
Should my tumor's genetics be tested? Yes — some bile duct cancers carry specific gene changes, such as FGFR2 fusions or IDH1 mutations, that can be treated with targeted drugs. Testing the tumor's genetics, particularly in advanced disease, can open up additional treatment options.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.